1. Home
  2. LEN vs KVUE Comparison

LEN vs KVUE Comparison

Compare LEN & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lennar Corporation

LEN

Lennar Corporation

HOLD

Current Price

$89.86

Market Cap

31.0B

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.45

Market Cap

34.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEN
KVUE
Founded
1954
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Specialty Chemicals
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
31.0B
34.9B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
LEN
KVUE
Price
$89.86
$17.45
Analyst Decision
Hold
Buy
Analyst Count
15
11
Target Price
$103.46
$19.73
AVG Volume (30 Days)
2.6M
25.1M
Earning Date
03-12-2026
05-07-2026
Dividend Yield
2.13%
4.76%
EPS Growth
N/A
40.74
EPS
N/A
0.76
Revenue
N/A
$15,124,000,000.00
Revenue This Year
N/A
$4.80
Revenue Next Year
$4.82
$2.52
P/E Ratio
$15.20
$22.96
Revenue Growth
N/A
N/A
52 Week Low
$92.17
$14.02
52 Week High
$144.24
$25.17

Technical Indicators

Market Signals
Indicator
LEN
KVUE
Relative Strength Index (RSI) 25.12 39.50
Support Level N/A $17.14
Resistance Level $118.16 $17.89
Average True Range (ATR) 2.96 0.30
MACD -0.93 -0.11
Stochastic Oscillator 3.05 10.00

Price Performance

Historical Comparison
LEN
KVUE

About LEN Lennar Corporation

Lennar is one of the largest public homebuilders in the United States. The company's homebuilding operations target first-time, move-up, active adult, and luxury homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily and single-family for-rent construction and has invested in numerous housing-related technology startups.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Share on Social Networks: